Advertisement
| science venture: Venture Work Alexander Styhre, 2018-12-30 This book contributes to the ongoing discussion around so-called precarious or venture work, as the proportion of those employed by start-ups and thinly-capitalized firms continues to grow. Filling a gap in literature, the author explores the relationship between venture co-workers and examines how they cope with economic uncertainty, moving away from the previous focus on entrepreneurs and investors. Presenting empirical data from several life science start-ups in Sweden, this book illustrates the impact of institutional and regulatory changes in the finance industry, and demonstrates how these effects can ultimately reshape the meaning of employment. |
| science venture: Venture Investing in Science Douglas W. Jamison, Stephen R. Waite, 2017-06-06 Over the past decade, software companies have increasingly monopolized the flow of venture capital, starving support for scientific research and its transformative discoveries. New medicines, cheaper and faster personal computers, and other life-changing developments all stem from investment in science. In the past, these funds led to steam engines, light bulbs, microprocessors, 3D printers, and even the Internet. In Venture Investing in Science, the venture capitalist Douglas W. Jamison and the investment author Stephen R. Waite directly link financial support to revolutionary advancements in physics, computers, chemistry, and biology and make a passionate case for continued investing in science to meet the global challenges of our time. Clean air and water, cures for intractable diseases, greener public transportation, cheaper and faster communication technologies—these are some of the rich opportunities awaiting venture capital investment today. Jamison and Waite focus on how early-stage companies specializing in commercializing transformative technologies based on deep science have been shunned by venture capitalists, and how the development of such companies have been hampered by structural changes in capital markets and government regulation over the past decade. The authors argue that reinvigorating science-based technological innovation is crucial to reactivating the economic dynamism that lifts living standards and fuels prosperity over time. |
| science venture: A Daring Venture (An Empire State Novel Book #2) Elizabeth Camden, 2018-06-05 As a biochemist in early 1900s New York, Doctor Rosalind Werner has dedicated her life to the crusade against waterborne diseases. She is at the forefront of a groundbreaking technology that will change the way water is delivered to every household in the city--but only if she can get people to believe in her work. Newly appointed Commissioner of Water for New York, Nicholas Drake is highly skeptical of Rosalind and her team's techniques. When a brewing court case throws him into direct confrontation with her, he is surprised by his reaction to the lovely scientist. While Rosalind and Nick wage a private war against their own attraction, they stand firmly on opposite sides of a battle that will impact far more than just their own lives. As the controversy grows more public and inflammatory and Rosalind becomes the target of an unknown enemy, the odds stacked against these two rivals swiftly grow more insurmountable with every passing day. |
| science venture: BoogarLists | Directory of Bio-Life Sciences Venture Capital , |
| science venture: Status and Organizations Alexander Styhre, 2022-08-25 This book examines social status as a social mechanism and a social fact that strongly shapes how markets and organizations are regulated, managed, and preserved over time. The first part of this book identifies a number of organizational issues and managerial concerns that can be framed as being a matter of the cognitive perspectives of social actors, and better explained on the basis of such conditions. The second part demonstrates the analytical value of the concept of status in a variety of organizational settings and market contexts. In the three empirical settings, status does play a key role when resources such as legitimacy (in urban development projects), revenues from sales (in video game marketing), and access to venture capital (in life science companies) are distributed. This book summarizes and reviews the academic literature on status and organization studies, as well as providing valuable information for researchers conducting empirical testing. It will be of great interest to students and scholars of Organizations and Social Systems. |
| science venture: BoogarLists | Directory of Venture Capital & Private Equity , |
| science venture: Financing Life Science Innovation A. Styhre, 2015-04-21 Financing Life Science Innovation reviews the literature on venture capital, corporate governance, and life science venturing and presents a study of the Swedish life science industry and the venture capital investors being active in financially and managerially supporting life science start-up firms. |
| science venture: Religion and Science W. Mark Richardson, Wesley J. Wildman, 2012-10-12 Emphasizing its historical, methodological and constructive dimensions, Religion and Science takes the pulse of pertinent current research as the interdisciplinary study of science and religion gains momentum. |
| science venture: The Venture Capital State Robyn Klingler-Vidra, 2018-09-15 Silicon Valley has become shorthand for a globally acclaimed way to unleash the creative potential of venture capital, supporting innovation and creating jobs. In The Venture Capital State Robyn Klingler-Vidra traces how and why different states have adopted distinct versions of the Silicon Valley model. Venture capital seeks high rewards but is enveloped in high risk. The author’s deep investigations of venture capital policymaking in East Asian states (Hong Kong, Taiwan, Singapore) show that success does not reflect policymakers’ ability to replicate the Silicon Valley model. Instead, she argues, performance reflects their skill in adapting a highly lauded model to their local context. Policymakers are contextually rational in their learning; their context-rooted norms shape their preferences. The normative context for learning about policy—how elites see themselves and what they deem as locally appropriate—informs how they design their efforts. The Venture Capital State offers a novel conceptualization of rationality, bridging diametrically opposed versions of bounded and conventional rationality. This new understanding of rationality is simultaneously fully informed and context based, and it provides a framework by which analysts can bring domestic factors to the very heart of international diffusion of policy. Klingler-Vidra concludes that states have a visible hand in constituting even quintessentially neoliberal markets. |
| science venture: The Financialized Economy Alexander Styhre, 2021-04-04 Social science theorists from various scholarly disciplines have contributed to a recent literature that examines how the finance industry has expanded and now wields increasing influence across a variety of economic fields and industries. In some cases, this tendency towards a more sizeable and influential finance industry has been referred to as the financialization of the economy. This book explains how what is referred to as the finance-led economy (arguably a more neutral and less emotionally charged term than financialization) is premised on a number of conditions, institutional relations, and theoretical propositions and assumptions, and indicates what the real economic consequences are for market actors and households. The book provides a theoretically condensed but empirically grounded account of the contemporary finance-led economy, in many cases too complicated in its design and rich in detail to be understood equally by insiders—empirical research indicates—and lay audiences. It summarizes the relevant literature and points at two empirical cases, the construction industry and life science venturing, to better illustrate how the expansion of the finance industry has contributed to the capital formation process, and how the sovereign state has actively assisted this process. It offers a credible, yet accessible overview of the economic conditions that will arguably shape economic affairs for the foreseeable future. The book will find an audience amongst a variety of readers, including graduate students, management scholars, policymakers, and management consultants. |
| science venture: Investments in Life Science Real Estate Sandro Jäger, Michael Trübestein, Matthias Daniel Aepli, 2024-07-25 The book empirically analyzes the market, drivers, trends, and building characteristics of life sciences real estate. The findings suggest significant growth potential, supported by strong market fundamentals and demographics. Investors are drawn to the sector's potential for risk-adjusted returns, capital and rental growth, and defensive characteristics. Nevertheless, the high specifications and complexity of laboratories present challenges, including high capital expenditures, maintenance costs, and the need for specialized expertise and networks. The trend towards flexible and modular laboratories and the conversion of traditional assets into lab spaces offer exciting opportunities for investments in life sciences real estate. Life sciences real estate has gained attention from investors seeking alternative options to traditional real estate sectors. This niche market has seen increased capital inflows and investor interest due to attractive returns and risk diversification. The industry encompasses various specialized subdisciplines, each with unique building and space requirements. However, the complexity and diversity of the sector pose challenges for investors in evaluating advantages, disadvantages, and risks. This textbook has been recommended and developed for universitary courses in Germany, Austria and Switzerland. |
| science venture: Life Science Management Avo Schönbohm, Hans Henning von Horsten, Philipp Plugmann, 2022-07-14 The COVID-19 pandemic has reminded us of how important the life science industry is, and compels us to find efficient management methods specific to the industry. Pharmaceuticals, drug and vaccine development labs, R&D labs, medical instrumentation, and tech companies, hygiene supply companies, medical distribution chains, all form an integral part of this industry. At the interface of scientific research, technology, innovation and management and embedded in regulatory and legal frameworks, life science management is still an under-researched field of practice and science. This edited volume addresses this research gap and offers a wide range of practical and theoretical contributions that provide insights into one of the most exciting industries. The book is primarily directed at practitioners and decision makers in the life science industry. Students and professionals of life science management at all levels as well as policy makers will find valuable insights and inspiration for their daily work and career development. |
| science venture: Social Entrepreneurship in the Middle East Dima Jamali, Alessandro Lanteri, 2016-04-29 This two-volume book unveils trends, strengths, weaknesses and overall dynamics and implications of social entrepreneurship in the Middle East region, whilst identifying both opportunities and threats facing social entrepreneurship and supplements through a wealth of insights and examples inspired from practice and current applications. |
| science venture: Private Equity 4.0 Benoît Leleux, Hans van Swaay, Esmeralda Megally, 2015-01-20 “Private equity is more economically significant than ever, as institutions hunt for high returns in a risky world. Private Equity 4.0 examines the role, workings and contribution of this important industry in a straightforward yet revealing manner.” Dr. Josh Lerner Jacob H. Schiff Professor of Investment Banking Chair, Entrepreneurial Management Unit Harvard Business School A multi-perspective look at private equity's inner workings Private Equity 4.0 provides an insider perspective on the private equity industry, and analyzes the fundamental evolution of the private equity asset class over the past 30 years, from alternative to mainstream. The book provides insightful interviews of key industry figures, and case studies of some of the success stories in the industry. It also answers key questions related to strategy, fund manager selection, incentive mechanisms, performance comparison, red flags in prospectuses, and more. Private Equity 4.0 offers guidance for the many stakeholders that could benefit from a more complete understanding of this special area of finance. Understand the industry's dominant business models Discover how value is created and performance measured Perform a deep dive into the ecosystem of professionals that make the industry hum, including the different incentive systems that support the industry's players Elaborate a clear set of guidelines to invest in the industry and deliver better performance Written by a team of authors that combine academic and industry expertise to produce a well-rounded perspective, this book details the inner workings of private equity and gives readers the background they need to feel confident about committing to this asset class. Coverage includes a historical perspective on the business models of the three major waves of private equity leading to today's 4.0 model, a detailed analysis of the industry today, as well as reflections on the future of private equity and prospective futures. It also provides readers with the analytical and financial tools to analyze a fund's performance, with clear explanations of the mechanisms, organizations, and individuals that make the system work. The authors demystify private equity by providing a balanced, but critical, review of its contributions and shortcomings and moving beyond the simplistic journalistic descriptions. Its ecosystem is complex and not recognizing that complexity leads to inappropriate judgments. Because of its assumed opacity and some historical deviant (and generally transient) practices, it has often been accused of evil intents, making it an ideal scapegoat in times of economic crisis, prodding leading politicians and regulators to intervene and demand changes in practices. Unfortunately, such actors were often responding to public calls for action rather than a thorough understanding of the factors at play in this complex interdependent system, doing often more harm than good in the process and depriving economies of one of their most dynamic and creative forces. Self-regulation has clearly shown its limits, but righteous political interventions even more so. Private equity investment can be a valuable addition to many portfolios, but investors need a clear understanding of the forces at work before committing to this asset class. With detailed explanations and expert insights, Private Equity 4.0 is a comprehensive guide to the industry ways and means that enables the reader to capture its richness and sustainability. |
| science venture: The Impact of Medical Device and Drug Regulation on Innovation, Jobs, and Patients United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, 2012 |
| science venture: International Entrepreneurship in the Life Sciences Marian V. Jones, Colin Wheeler, Pavlos Dimitratos, 2011-11-01 'The processes of internationalization, innovation and venture-creation in high-technology new ventures are inextricably intertwined. This is particularly true in the uncertain and troubled waters of the life sciences industry where startups with very uncertain futures are required to face significant challenges in short windows of opportunity. Navigating these waters is not straightforward, either for those immediately involved in it, or for those trying to understand it. This book is a must-read for anyone who is serious about understanding entrepreneurship in the biotechnology industry.' Alberto Onetti, CrESIT (Research Center for Innovation and Life Science Management), Italy In this thought-provoking book, leading experts explore why international entrepreneurship is important to the life sciences industry. From multi-disciplinary and cross-national perspectives, they question why international entrepreneurship scholars might usefully invest interest in research focused on one specific industry context. The book addresses contemporary challenges of relevance to life science firms and draws on leading-edge debates in international entrepreneurship research. Topics include: the nature of the born-global firm; the development of international capabilities and competencies; the role of local and international partnerships and alliances; competitiveness, opportunity recognition and orientation; and the role of specialized complementary assets in internationalization. It concludes by proposing an agenda for future research across the underpinning fields of innovation, entrepreneurship and internationalization. This book will prove a stimulating read for academics, students and researchers with an interest in international business, management and entrepreneurship, as well as for practitioners in the health professions or life sciences academics who are, or may become, entrepreneurs. |
| science venture: The Biologist's Imagination William Hoffman, Leo Furcht, 2014-05-01 Scholars and policymakers alike agree that innovation in the biosciences is key to future growth. The field continues to shift and expand, and it is certainly changing the way people live their lives in a variety of ways. With a large share of federal research dollars devoted to the biosciences, the field is just beginning to live up to its billing as a source of innovation, economic productivity and growth. Vast untapped potential to imagine and innovate exists in the biosciences given new tools now widely available. In The Biologist's Imagination, William Hoffman and Leo Furcht examine the history of innovation in the biosciences, tracing technological innovation from the late eighteenth century to the present and placing special emphasis on how and where technology evolves. Place is often key to innovation, from the early industrial age to the rise of the biotechnology industry in the second half of the twentieth century. The book uses the distinct history of bioinnovation to discuss current trends as they relate to medicine, agriculture, energy, industry, ecosystems, and climate. Fast-moving research fields like genomics, synthetic biology, stem cell research, neuroscience, bioautomation and bioprinting are accelerating these trends. Hoffman and Furcht argue that our system of bioscience innovation is itself in need of innovation. It needs to adapt to the massive changes brought about by converging technologies and the globalization of higher education, workforce skills, and entrepreneurship. The Biologist's Imagination is both a review of past models for bioscience innovation and a forward-looking, original argument for what future models should take into account. |
| science venture: Silicon Valley Bank Xuan-Thao Nguyen, 2024-02-15 This book provides a first-hand account of the founding, ascent, and dissolution of Silicon Valley Bank (SVB), a tech community bank founded in 1982 with US$5 million that became the nation's 13th largest bank and tech industry's lender and bank. In this pathbreaking work, which challenges conventional understanding of risky tech lending by showing how an independent community bank became the go-to bank for the tech industry in the United States, Xuan-Thao Nguyen includes interviews with key players, ranging from the original founders and early employees to the current CEO of SVB. Chapters explore how the relationship between the venture capital (VC) industry and SVB transformed the way commercial banks comply with banking regulators while lending and nurturing young tech clients. The book demonstrates why the relationships between investors, start-ups, bankers, lenders, experts, lawyers, regulators, and community leaders are key ingredients for ongoing innovation in the tech industry. The book concludes with the sobering dissection of SVB's sudden death by $142 billion cuts inflicted by tech bros, social media, and the Federal Reserve Bank's successive interest rate hikes to squash the overheated economy. |
| science venture: Indicating Value in Early-Stage Technology Venture Valuation Christoph Philipp Wessendorf, 2021-08-24 Fundraising for venture capital investments have continued to increase in recent years. One crucial step in the investment process is the valuation of the target company. Investors are faced with the great challenge of valuing a young venture without a corporate or financial history, a firm customer relationship or even a business model, while still taking into account the tremendous growth potential. Especially the valuation of technology companies is a difficult and often subjective process. Motivated by these considerations, this dissertation details a design science research project, which aims to develop an artifact that improves the indication of value in early-stage technology venture valuation while enabling operationalizable and fair valuation. This approach ensures a more meaningful valuation and better applicability to early-stage technology ventures compared to traditional methods while supporting the deliberate reduction of information asymmetries between entrepreneurs and investors. Firm-specific characteristics and practical applicability are taken into account. |
| science venture: The Emergence of Organizations and Markets John F. Padgett, Walter W. Powell, 2012-10-14 A dynamic framework for studying social emergence The social sciences have sophisticated models of choice and equilibrium but little understanding of the emergence of novelty. Where do new alternatives, new organizational forms, and new types of people come from? Combining biochemical insights about the origin of life with innovative and historically oriented social network analyses, John Padgett and Walter Powell develop a theory about the emergence of organizational, market, and biographical novelty from the coevolution of multiple social networks. They demonstrate that novelty arises from spillovers across intertwined networks in different domains. In the short run actors make relations, but in the long run relations make actors. This theory of novelty emerging from intersecting production and biographical flows is developed through formal deductive modeling and through a wide range of original historical case studies. Padgett and Powell build on the biochemical concept of autocatalysis—the chemical definition of life—and then extend this autocatalytic reasoning to social processes of production and communication. Padgett and Powell, along with other colleagues, analyze a very wide range of cases of emergence. They look at the emergence of organizational novelty in early capitalism and state formation; they examine the transformation of communism; and they analyze with detailed network data contemporary science-based capitalism: the biotechnology industry, regional high-tech clusters, and the open source community. |
| science venture: Edison in the Boardroom Revisited Suzanne S. Harrison, Patrick H. Sullivan, 2011-12-06 A revised and expanded edition of the groundbreaking Edison in the Boardroom, highlighting the winning strategies today's biggest companies use to maximize the value of their intellectual property Now fully revised and expanded, Edison in the Boardroom, Second Edition takes an in-depth look at the revolutionary concept of intellectual asset management (IAM). Incorporating stories and teachings from some of the most successful companies in the world—such as Hewlett-Packard, IBM, Procter & Gamble, Rockwell, Dow, Ford and many others—Harrison and Sullivan have made an exhaustive study of IAM and its implications for today's businesses. Features updated interviews of companies, and a new treatment of the Profit Center Level Updates stories and teachings from some of the most successful companies in the world Showcases a hierarchy of best practices that today's companies can integrate into their own business philosophies to gain the best return from their intellectual assets Edison in the Boardroom, Second Edition compiles a wealth of knowledge and successful stories that illustrate how far businesses have come in their ability to leverage and monetize their intellectual assets. |
| science venture: Invention to Innovation Dr Larry Marshall, 2023-06-05 Invention to Innovation charts a course for scientists, leaders, investors and policy makers to translate research into growing innovative, competitive companies and industries. With extensive experience and insights gained over three decades, Dr Larry Marshall demonstrates how science can generate new value that grows markets and creates jobs while also delivering social, environmental and economic benefits. Through a combination of advice, examples and vision, this thought-provoking work shows how Australia’s world-class science can navigate across the ‘Valley of Death’ to become successful innovations and grow our economy. With contributions from leaders in business, research, venture and scientists who have made the leap to become ‘scientist CEOs’, Invention to Innovation is essential reading for anyone who believes Australia’s excellent science deserves a vibrant, globally competitive innovation ecosystem to ensure our sustainable and prosperous future. Praise for Invention to Innovation: The Digital Future has huge potential to unlock new waves of innovation and economic prosperity for all Australians. It's a future where Aussie kids see Aussie scientists and Aussie entrepreneurs solve Australian problems and take them to the world. Larry is passionate about this future for our children, and this book is all about how to make it happen. Melanie Silva, Managing Director of Google Australia and New Zealand Powered by his extensive scientific entrepreneurship, Dr Larry Marshall shows us how to couple science with innovation to produce prosperity. Human ingenuity is an inexhaustible resource; this book explains how to mine it and refine it into societal value. Dr Alan Finkel, former Australian Chief Scientist, President of the Australian Academy of Technology and Engineering, Chancellor of Monash University, CEO and Founder of Axon Instruments For Australia’s budding technology entrepreneurs, [Invention to Innovation] is an excellent ‘how to’ manual, full of practical advice, and offering useful, tangible guidance on how our scientists and entrepreneurs can seize the tremendous opportunities Australia offers. Michelle Simmons, CEO and Founder of Silicon Quantum Computing and 2018 Australian of the Year Few scientists have transitioned to become business leaders, or to create public companies, but Larry Marshall has done just that – and by sharing uncomfortable truths, failures and successes, all anchored by the real life experience of someone who has crossed the Valley of Death more than once, Larry seeks to provide other scientists with the confidence that, they too, can do it. Catherine Livingstone, AO, former Chair of CSIRO, Commonwealth Bank and Telstra; former President of the Business Council of Australia; and former CEO of Cochlear Australia has a proud history of scientific research and industrial innovation. But despite this, we’ve got a lousy track record of translating this innovation into real impact, especially commercial impact. ... We will only succeed if we try. This book is an important first step towards success. Dr Andrew Forrest, AO, Chairman and Founder of Fortescue Metals Group, Fortescue Future Industries, Minderoo Foundation and Tattarang |
| science venture: The Venture Capital Cycle Paul Alan Gompers, Joshua Lerner, 2004 An analysis of the venture capital process, from fund-raising through investing to exiting investments; a new edition with major revisions and six new chapters that reflect the latest research. |
| science venture: A Prescription for Savings United States. Congress. Senate. Special Committee on Aging, 2011 |
| science venture: Success With Investors Guide , |
| science venture: Finance, Innovation and Geography Felix C. Müller, 2019-04-24 The overarching aim of Finance, Innovation and Geography: Harnessing Knowledge Dynamics in German Biotechnology is to explore linkages between geographies of finance and relational geographies of innovation. This is achieved by questioning how investment activities affect the unfolding of innovations and in turn are affected by it. This book focuses on biotechnology innovation processes from the perspective of relational economic geography. It reconstructs the unfolding in time and space of eight innovations in German biotechnology. Each one is represented in a qualitative case study. The analysis focuses on the relational work of building, transforming, ending and replacing of collaborative relationships and organizational arrangements surrounding emergent innovations ・ including investment relations and relational work by investors. In this way, the contribution of investors to unfolding innovations is studied with sensitivity to context and situated interactions. The geography of these dynamics is conceptualized by drawing on the recent literature on relational proximity and distance as well as ideas of materiality and space. This book provides a unique perspective, and shows that innovation paths are strongly interwoven with local and temporary opportunities as well as crises, and that investment is embedded in these dynamics. This is essential reading for students and academics of both economics and innovation. |
| science venture: New Venture Creation Marc H. Meyer, Frederick G. Crane, 2013-01-04 Structured around the idea that innovation is at the core of successful entrepreneurship, New Venture Creation: An Innovator's Guide to Startups and Corporate Ventures, Second Edition by Marc H. Meyer and Frederick G. Crane is an insightful, applied-methods guide that establishes innovation as a necessary first step before writing a business plan or developing a financial model. With a focus on pragmatic methods, this guide helps students develop the innovative concepts and business plans they need to raise start-up capital. |
| science venture: Plant Development and Biotechnology Robert N. Trigiano, Dennis J. Gray, 2004-07-28 Biotechnology revolutionized traditional plant breeding programs. This rapid change produced new discussions on techniques and opportunities for commerce, as well as a fear of the unknown. Plant Development and Biotechnology addresses the major issues of the field, with chapters on broad topics written by specialists. The book applies an informal s |
| science venture: Improving Technology Transfer at Universities, Research Institutes, and National Laboratories United States. Congress. House. Committee on Science, Space, and Technology (2011). Subcommittee on Research and Technology, United States. Congress. House. Committee on Science, Space, and Technology (2011- ). Subcommittee on Research and Technology, 2013 |
| science venture: The SME Financing Gap (Vol. II) Proceedings of the Brasilia Conference, 27-30 March 2006 OECD, 2007-04-17 A synthesis of the Conference discussions as well as selected papers on the credit and equity financing gaps, as well as on private equity definitions and measurements. |
| science venture: Circle of Life , |
| science venture: A Deliberate Pause Larry Robertson, 2009-10-01 A deliberate pause is a conscious moment in which we open our minds and ask “why are things the way they are?” and wonder “how could life be better?” Pausing to ask such questions is a natural and uniquely human inclination. It’s also the critical factor that sparks fresh ideas and is seized by entrepreneurs to catalyze seismic changes—ones that allow humanity to progress. A Deliberate Pause (the book) reveals the power of a deliberate pause (the action) while unveiling unexpected truths about entrepreneurship itself. Through example, exploration, and analysis of the innovative thoughts and achievements of more than 200 seasoned entrepreneurial leaders, Larry Robertson shows how each of us can adopt a deliberate pause and an entrepreneurial mindset to better our lives, our species, and our world. In the process, he gives us the understanding of entrepreneurship we’ve been missing—and need now more than ever. |
| science venture: The Nationalization of the Social Sciences Samuel Z. Klausner, Victor M. Lidz, 2016-11-11 This book is a volume in the Penn Press Anniversary Collection. To mark its 125th anniversary in 2015, the University of Pennsylvania Press rereleased more than 1,100 titles from Penn Press's distinguished backlist from 1899-1999 that had fallen out of print. Spanning an entire century, the Anniversary Collection offers peer-reviewed scholarship in a wide range of subject areas. |
| science venture: Technology Financing and Commercialization J. Wonglimpiyarat, 2014-11-27 This book offers insights on effective policies that can be applied to other economies in terms of using technology financing to foster technological innovations. It outlines the role of government in accelerating the nation's innovative capacity by promoting technology investments that will achieve successful and sustainable economic development. |
| science venture: Better Venture Erika Brodnock, Johannes Lenhard, 2020-11-11 Better Venture is a first-of-its-kind guide to diversity and inclusion in startups and venture capital—who funds, who gets funded, and how the industry can change. The industry’s lack of diversity and inclusion not only compromises moral standing—it means overlooking profitable businesses and talented founders. That costs hundreds of millions of dollars a year, and neglects ideas that could serve the needs of many more people. In this collection of interviews, stories, and research, we use the momentum that has been building in recent years to expand the conversation about DEI, venture capital, and the startup ecosystem, and to inspire more concrete action. Highlights: - 43 in-depth conversations with leading investors, entrepreneurs, and researchers, making it one of the most comprehensive and diverse sets of perspectives on the startup ecosystem ever assembled in one place. - An economic history of venture capital through a diversity lens. - On-the-ground stories from founders and VCs that explore ways to create a more diverse, inclusive, equitable, and profitable venture ecosystem. No blog post can give the deep understanding and vision needed to address the complexity of the topic. That’s why we came together to write this book and are bringing in so many voices to clarify the picture of what is and what could be. Over the course of two years of research and discussion with almost 100 experts, we set out to answer four questions: - Why has the industry been so slow to change? We map the economic origins and history of venture capital to understand how the economics of VC has contributed to the glacial pace of diversifying the industry. - What barriers are founders and investors facing now? We draw on contributions from investors, operators, founders, and journalists to help catalog the barriers for founders seeking funding, and for investors seeking entry and influence in the industry. - Can diversity really lead to higher returns? We bring in new research and data to help us understand how betting on underrepresented founders and investors is really the better venture. Why does diversifying the industry matter, and to whom? How is it linked to financial performance and better decision making? How will it improve innovation across industries? - What can be done for positive change? We discuss cost effective and evidence-based interventions, tools, and solutions that can help to make the VC and startup worlds more diverse and inclusive—and result in higher returns. We hope this book and the conversations it contains help fulfill the vision of a more diverse, inclusive, and profitable ecosystem. It’s time venture got better. |
| science venture: Bridging Islands Robert Kneller, 2007-08-23 Bridging Islands is a detailed examination of the key role of venture companies in national technical and economic success, contrasting the industrial and social organization of the world's two largest economies, the US and Japan. The author argues that national policy on venture companies is of paramount importance to their economic growth. |
| science venture: Biotech Funding Trends Alexandra Carina Gruber, 2008-12-17 Based on interviews with successful biotech entrepreneurs and high-level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment. A must-have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry. |
| science venture: From Breakthrough to Blockbuster Donald L. Drakeman, Lisa N. Drakeman, Nektarios Oraiopoulos, 2022 From Breakthrough to Blockbuster: The Business of Biotechnology tells the astonishing story of how the biotech industry grew to thousands of small companies around the world, competing with the major pharmaceutical companies that had dominated for a century, and how academic research, venture capital, and contract research organizations worked together to support them. |
| science venture: Responsible People Francisca Farache, Georgiana Grigore, Alin Stancu, David McQueen, 2019-04-11 This book brings the focus of corporate responsibility back to the people who are driving change in contemporary practice. Expanding current conceptualizations of CSR, the chapters come together to explore the work of a range of individuals in charge of CSR practices in contributing to societal good. Including topics such as leadership, social entrepreneurship, responsible management education, non-profit organizations and citizen activism, it aims to expand current mainstream understanding of the role individuals have in shaping CSR theory, practice, policies, and discourses. |
| science venture: Biotechnology Law and Practice Wen De Keesee, 2021-04-15 The Biotech Gold Rush is On! What are you waiting for? We are entering an explosive new era of medical and scientific discovery and the opportunities are huge for those who grasp the moment This Biotechnology Law and Practice Four book series is the most current, and informative work of its kind, and heralded by lawyers, scientists, and entrepreneurs as a must-have guidebook which simplifies complex issues at the frontiers of the law and biomedicine. With over 1600 power-packed pages of bioscience-biotech law, intellectual property, biomedicine, pharmaceuticals, regulatory, business strategies, and entrepreneurship, these books will launch you into this explosive new field, and you will have a precious asset, which you may routinely consult on your great new quest. Biotech Stocks are on fire! Potentially 100’s of new little biotech companies will develop new generations of medicines and medical devices while creating vast numbers of new millionaires. |
Science News | The latest news from all areas of science
Jun 1, 2025 · Science News features news articles, videos and more about the latest scientific advances. Independent, accurate nonprofit news since 1921.
All Topics - Science News
6 days ago · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology.
March 2025 | Science News
Mar 1, 2025 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology.
News | Science News
6 days ago · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology.
The long and short of science
May 24, 2025 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our …
Year in Review 2024 - Science News
Dec 18, 2024 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our …
Meet Chonkus, the mutant cyanobacteria that could help
Nov 7, 2024 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our mission …
Life | Science News
5 days ago · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology.
Century of Science
Jan 13, 2021 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our …
As quantum mechanics turns 100, a new revolution is under way
May 20, 2025 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our …
Science News | The latest news from all areas of science
Jun 1, 2025 · Science News features news articles, videos and more about the latest scientific advances. Independent, accurate nonprofit news since 1921.
All Topics - Science News
6 days ago · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology.
March 2025 | Science News
Mar 1, 2025 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology.
News | Science News
6 days ago · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology.
The long and short of science
May 24, 2025 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our …
Year in Review 2024 - Science News
Dec 18, 2024 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our …
Meet Chonkus, the mutant cyanobacteria that could help
Nov 7, 2024 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our …
Life | Science News
5 days ago · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology.
Century of Science
Jan 13, 2021 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our …
As quantum mechanics turns 100, a new revolution is under way
May 20, 2025 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our …
